Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14735821rdf:typepubmed:Citationlld:pubmed
pubmed-article:14735821lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:14735821lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:14735821lifeskim:mentionsumls-concept:C1719822lld:lifeskim
pubmed-article:14735821lifeskim:mentionsumls-concept:C0522536lld:lifeskim
pubmed-article:14735821lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:14735821pubmed:issue2lld:pubmed
pubmed-article:14735821pubmed:dateCreated2004-1-22lld:pubmed
pubmed-article:14735821pubmed:abstractTextAn evaluation of the long-term survival rate of 25 osteoarticular allografts was made. Clinical analysis was based on the Mankin scale and the Musculoskeletal Tumor Society (MSTS) Grading system. After a mean follow-up time of 15 years 76% of the osteoarticular allografts had good or excellent rating. The MSTS scale revealed a mean score of 89% for those 20 grafts still functioning according to their primary purpose. Allograft related complications occurred in 32% of the cases being most common among malignant cases. Due to the rather good long-term results, osteoarticular allografts can still be recommended for hemicondylar allograft reconstruction in benign lesions.lld:pubmed
pubmed-article:14735821pubmed:languageenglld:pubmed
pubmed-article:14735821pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14735821pubmed:citationSubsetIMlld:pubmed
pubmed-article:14735821pubmed:statusMEDLINElld:pubmed
pubmed-article:14735821pubmed:issn0009-4749lld:pubmed
pubmed-article:14735821pubmed:authorpubmed-author:LaitinenMMlld:pubmed
pubmed-article:14735821pubmed:authorpubmed-author:HiroNNlld:pubmed
pubmed-article:14735821pubmed:authorpubmed-author:AhoAAlld:pubmed
pubmed-article:14735821pubmed:issnTypePrintlld:pubmed
pubmed-article:14735821pubmed:volume88lld:pubmed
pubmed-article:14735821pubmed:ownerNLMlld:pubmed
pubmed-article:14735821pubmed:authorsCompleteYlld:pubmed
pubmed-article:14735821pubmed:pagination143-8lld:pubmed
pubmed-article:14735821pubmed:dateRevised2010-6-18lld:pubmed
pubmed-article:14735821pubmed:meshHeadingpubmed-meshheading:14735821...lld:pubmed
pubmed-article:14735821pubmed:meshHeadingpubmed-meshheading:14735821...lld:pubmed
pubmed-article:14735821pubmed:meshHeadingpubmed-meshheading:14735821...lld:pubmed
pubmed-article:14735821pubmed:meshHeadingpubmed-meshheading:14735821...lld:pubmed
pubmed-article:14735821pubmed:meshHeadingpubmed-meshheading:14735821...lld:pubmed
pubmed-article:14735821pubmed:meshHeadingpubmed-meshheading:14735821...lld:pubmed
pubmed-article:14735821pubmed:meshHeadingpubmed-meshheading:14735821...lld:pubmed
pubmed-article:14735821pubmed:articleTitleSurvival of 25 osteoarticular allografts followed more than 10 years.lld:pubmed
pubmed-article:14735821pubmed:affiliationDivision of Orthopaedics, Department of Surgery, University Hospitals of Tampere, Finland.lld:pubmed
pubmed-article:14735821pubmed:publicationTypeJournal Articlelld:pubmed